Next Article in Journal
Comparison of Secular Trends in Peptic Ulcer Diseases Mortality in China, Brazil and India during 1990–2019: An Age-Period-Cohort Analysis
Previous Article in Journal
Overview on and Contextual Determinants of Medical Residencies in North Brazil
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Assessment of Public’s Awareness Regarding Irritable Bowel Syndrome in Aseer Region, Saudi Arabia

by
Mohammed A. Bawahab
1,
Muneer Jan Bhat
1,*,
Fahad Nasser Mohammed Asiri
1,
Khalid Ali Mohammed Alshahrani
1,
Abdulaziz Mohammed Alshehri
1,
Bassam Ahmed Almutairi
1,
Muath Mohammed Alhumaidi
1 and
Rayan M. Eskandar
2
1
Surgery Department, Faculty of Medicine, King Khalid University, Abha P.O. Box 641, Saudi Arabia
2
Ibn Sina Medical College, Jeddah P.O. Box 641, Saudi Arabia
*
Author to whom correspondence should be addressed.
Healthcare 2023, 11(8), 1084; https://doi.org/10.3390/healthcare11081084
Submission received: 1 March 2023 / Revised: 29 March 2023 / Accepted: 6 April 2023 / Published: 11 April 2023
(This article belongs to the Section Preventive Medicine)

Abstract

:
Irritable bowel syndrome (IBS) is a gastrointestinal disorder characterized by altered bowel habits, abdominal pain, or discomfort. It is a highly prevalent disorder that affects patients’ quality of life. A workup is usually required to diagnose IBS, as its differential diagnosis includes some serious conditions such as carcinoma of the colon. The present study aimed to assess the awareness and beliefs of the general population regarding IBS. This study was conducted in the Aseer Region, in the southwestern part of Saudi Arabia. It followed a cross-sectional research design that was conducted during the period from January to March 2021 using a structured self-administered questionnaire to assess the demographic variables in addition to questions to assess participants’ awareness and beliefs related to IBS. Following a convenience sample, the study included 779 participants, with 43.3% being male, mostly in the age group 21–30 years (36.7%), and 68.7% being university graduates. Most participants (70.5%) were aware of IBS, and had the correct knowledge about its etiology, symptoms, risk factors, prognosis, and management. It is recommended to conduct various awareness-raising programs regarding IBS to improve the public’s knowledge and to decrease functional disabilities and their impact on life.

1. Introduction

Functional gastrointestinal disorders (FGID), such as functional dyspepsia (FD) and irritable bowel syndrome (IBS), are featured by chronic or recurrent abdominal symptoms of pain. In the case of irritable bowel syndrome (IBS), it is connected with either relief or exacerbation by defecation, or changes in bowel habits [1]. In addition, changes in bowel habits are related to both relief and exacerbation. Mood disorders, intestinal microbiota, chronic infections, altered intestinal permeability, and low-grade mucosal inflammation, including eosinophilia, systemic immune activation, altered bile salt metabolism, abnormalities in the serotonin metabolism, and genetic factors have all been proposed as potential causes of FGID [1].
Irritable bowel syndrome, often known as IBS, is a condition that affects the digestive tract and is characterized by stomach pain and chronic discomfort, as well as changes in the appearance of stools, mucus discharge, and bowel abnormalities [2,3]. IBS is not caused by any medical illness. It is a chronic and debilitating functional disorder of the gastrointestinal tract that affects 9–23% of the population across the world, causing a considerable impact on the quality of life, and resulting in functional disabilities [3]. According to the findings of a study that was carried out in the Al Jouf district of Saudi Arabia, the prevalence of IBS ranges between 8.9% and 9.2%. The incidence of irritable bowel syndrome (IBS) is considerably higher in persons under the age of 40 compared to those beyond the age of 40 [4].
The diagnosis of IBS is a matter of debate. Most community health providers believe that IBS is a diagnosis of exclusion; however, the guidelines emphasize that IBS is not a diagnosis of exclusion, and they encourage clinicians to make a positive diagnosis using the Rome criteria alone [5,6]. One of the most important differential diagnoses of IBS is colon cancer [7]. IBS and colon cancer share similar symptoms. Some patients with colon cancer may be misdiagnosed as having IBS. Nevertheless, with colon cancer, a person may experience unexplained weight loss and blood in their stool from the rectum. These symptoms do not occur in IBS. Despite similar symptoms, IBS does not put a person at a higher risk of developing colon cancer [8]. IBS frequently presents with serious symptoms that may be even more frequent than diabetes or hypertension [9]. However, the treatment of IBS is difficult because of its diversity and complexity. Although there are various guidelines related to its management, the main focus remains on the efficacy of medications using high-priority endpoints, leaving those of lower priority to be largely unreported.
There is poor knowledge about its prevalence, precipitating factors, and associated factors in Saudi Arabia [10]. To the best of our knowledge, there has been no study evaluating the knowledge of the general population regarding IBS. Thus, it is highly essential to have the basic knowledge and awareness of related symptoms and management of IBS. Hence, with this background, this study was conducted aiming to assess the knowledge, and related factors regarding IBS among the general population of the Saudi community in Aseer Region.

2. Methods

2.1. Study Design

The present study followed a cross-sectional research design. The study population included all Saudi adults (aged >18 years). However, those with a history of IBS, or who worked in the healthcare field were excluded. Following a convenience sample, a total of 779 participants could be included during the period from January to March 2021.

2.2. Data Collection Tool

Based on a thorough review of the relevant literature, a self-administered structured questionnaire was constructed by the researchers to assess participants’ personal characteristics (i.e., age, gender distribution, body mass index, marital status, residence, employment profile, and educational level), in addition to well-constructed questions regarding participants’ knowledge and attitude about IBS.
The study questionnaire’s content validity was assessed by an expert panel comprising two physicians and one research consultant. Moreover, the Cronbach α-coefficient was applied to measure its internal consistency, which proved to be appropriate (α = 0.84).

2.3. Data Collection

The study was conducted in accordance with the Declaration of Helsinki and was approved by the local ethics committee of the institute (ECM#2020-2402). Informed written consent was obtained from all subjects prior to their enrollment in the study. Patients were clearly informed about the questionnaire and the responses to all questions were recorded and analyzed.
The questionnaire was shared as an online questionnaire via various social media applications such as WhatsApp, Facebook, Twitter, Instagram, and Telegram, so as to achieve maximum responses from the general public and cover all types of education groups and subjects with a varied demographic profile. Moreover, face-to-face data collection was also performed by trained medical students in the form of direct interviews of the general population visiting public places, such as shopping malls and parks.

2.4. Outcomes

We evaluated participants’ personal characteristics (i.e., age, gender distribution, body mass index, marital status, residence, employment profile, and educational level) and their knowledge and attitude regarding IBS.

2.5. Statistical Analysis

All data were attained and recorded in a pre-designed and validated Excel sheet. Collected data were statistically analyzed using the Statistical Package for Social Sciences (IBM, SPSS, version 20.0). Descriptive statistics (i.e., mean, standard deviation, frequencies, and percentages) were computed. Testing the significance of differences was performed using the chi-square test. The level of significance was set at a p-value < 0.05. Testing the significance of differences was performed using the chi-square test. Binary logistic regression was applied to identify the independent variable significantly associated with public awareness of IBS. The level of significance was set at a p-value < 0.05.

3. Results

A combined total of one thousand people were invited through the use of social media and personal invitations. There were 822 responses that were accurate, which equates to 82.2%. Notwithstanding this, more participants with IBS and healthcare staff, totaling 43 patients, were excluded from the study. The total number of respondents was 779, which equates to a response rate of 77.9%.
Table 1 shows the personal characteristics of participants, with 43.3% being males. The age group of 36.7% was 21–30 years, while 8.6% were aged < 20 years. Most participants (79.2%) were living in the Aseer Region, Saudi Arabia, while 20.8% were temporary visitors to the area. More than half of the participants (58.0%) were married. More than two-thirds of the participants (68.7%) were university graduates, while 20.3% were secondary school qualified. Almost one-third of the participants (32%) were students, while 27.9% were teachers. More than one-third of the participants (39.5%) were overweight, while 24.1% were obese.
Figure 1 shows that most participants (70.5%) were aware of IBS, while 29.5% were not aware of it.
Table 2 shows participants’ responses regarding their awareness and knowledge of IBS. Almost half of the participants (49.4%) became aware of IBS from their friends or relatives, followed by the Internet and social media (36%). Almost one-third of participants (31.5%) stated that the most common symptoms of IBS include bouts of diarrhea, constipation, and abdominal cramps, while 60.8% stated that IBS is due to a colon infection.
More than half of the participants (54.6%) were not aware of the prevalence of IBS, while 28.8% correctly stated that IBS was more common than diabetes or hypertension, whereas 16.7% denied that. More than three-quarters of participants (79.5%) indicated that IBS affects the quality of life, while 92.3% stated that it could cause rapid mood changes. More than half of the participants stated that abdominal pain and excess gas are the most irritating symptoms of IBS that make the patient uncomfortable (62.4% and 56.4%, respectively), followed by constipation (36.6%), and diarrhea (8.1%). Almost half of the participants (48.9%) stated that dietary habits or food allergies are the most common etiological factors affecting patients with IBS, followed by genetic factors (38.1%), anxiety/depression/stress, infection (31.2%), and motility problems (1.5%). More than half of the participants stated that IBS can lead to ulcers and cancer (53.1% and 45.3%, respectively), followed by absorption disorders (30.4%), malnutrition (20.9%), and hemorrhoids (17.6%). A combination of multiple factors was stated by 43.6% of participants to be the most common triggering factor for IBS, followed by stress (31.2%), frequent and excessive intake of meals (16.3%), excessive intake of coffee (13.4%), excessive eating of meals containing saturated fats (5.5%), and eating spicy foods (5.1%). Most participants stated that dietary changes and medications could improve IBS symptoms (80% and 71.6%, respectively), whereas knowledge about the role of the surgery was not particularly known by most participants (70.6%). Most participants (76.6%) stated that counseling a physician could significantly improve the IBS status. The impact of advanced age was not well known by participants (46.2%), whereas only 21.8% confirmed its impact, and 32% denied its impact.
About one-third of participants (38.8%) stated that they advocate consulting a gastroenterologist for a relative who seeks advice regarding IBS, followed by recommending a change in diet (37.6%) or offering herbal medications (16.4%). About two-thirds of participants (67.7%) wished to know more about IBS, followed by which foods are to be avoided (11.7%), what causes IBS (4.6%), and lastly medications to prevent IBS attacks (0.1%).
Table 3 shows that participants’ awareness of IBS was significantly less common among females (p = 0.004), those aged more than 40 years (p < 0.001), married (p < 0.001), those with less than a university educational level (p = 0.037), and overweight and obese participants (p = 0.005).
Table 4 shows the binary logistic regression model for predictors of participants’ awareness of IBS. The odds ratio, i.e., Exp(B) for the significant independent variables was 6.4 for the participants’ gender, 5.37 for their age groups, 4.49 for their qualification, 3.69 for their marital status, and 3.54 for their body mass index. All the independent variables included had a statistically significant association with participants’ awareness of IBS (p < 0.001).

4. Discussion

The disorders of brain–gut interactions are a category of functional gastrointestinal disorders that are defined by a complicated relationship between the brain and the gut. They are also known as DGBIs. These conditions are characterized by a number of symptoms, including pain in the abdominal region, bloating, diarrhea, and constipation, all of which can have a major influence on a person’s quality of life [11]. Increasing pieces of evidence point to the possibility that alterations in the microbiota of the gut, the function of the intestinal barrier, and the immune system may all play a role in the pathogenesis of DGBIs. In addition, the impact that stress, worry, and depression has on the gut–brain axis have the potential to make the symptoms of DGBIs worse [12]. Recent developments in our knowledge of DGBIs have resulted in the creation of new diagnostic and therapeutic approaches for the treatment of these illnesses [13]. These include the use of probiotics, prebiotics, and dietary modifications in order to improve the composition and function of gut microbiota. Additionally, psychological therapies such as cognitive behavioral therapy and mindfulness-based interventions are utilized in order to target the psychological components of DGBIs [14]. In addition, there is evidence to suggest that novel pharmacological treatments, such as inhibitors of selective serotonin reuptake and certain neuromodulators, may have therapeutic benefits in the treatment of DGBIs [15]. In general, these new methods show promise for boosting the management of DGBIs and the quality of life of those who are afflicted by them.
Irritable bowel syndrome is a prevalent, commonly occurring, functional chronic gastrointestinal disorder that carries a considerably negative impact on social functioning and quality of life; thus, the condition should not be underestimated [16]. It is observed that during a person’s lifetime, one in every five persons suffers from IBS. Moreover, the number of persons taking medical advice regarding IBS is also increasing, which accounts for around 12% of the total patients visiting primary health care clinics. This group constitutes a major part of patients reporting to clinics of the gastroenterology department [10].
Anxiety and stress are known to make symptoms of irritable bowel syndrome (IBS) worse, which makes it more difficult to control the disease [17]. Anxiety and stress are known to trigger the release of hormones, such as adrenaline and cortisol, both of which have the potential to irritate and inflame the digestive tract [18]. In addition, anxiety and stress can upset the balance of bacteria in the gut, which can make the symptoms of irritable bowel syndrome (IBS) worse. Alterations to one’s diet, which can be brought on by anxiety and stress in certain people, might make the symptoms of irritable bowel syndrome (IBS) worse [19].
The incidence of irritable bowel syndrome (IBS) continues to vary greatly across the globe. The prevalence of irritable bowel syndrome (IBS) is significantly higher in females than it is in males. Individuals between the ages of 20 and 40 years old were affected the most frequently [10]. The prevalence of irritable bowel syndrome (IBS) is estimated to range anywhere from 9–40%, according to the findings of a number of studies that have been carried out all over the world [20,21,22]. Insufficient data are available regarding the prevalence of irritable bowel syndrome (IBS) and the factors that put people at risk in Saudi Arabia’s general population. Studies have also proposed that the incidence of IBS can also be affected by various genetic factors, where family history plays an important role in the development of IBS in around 30% of patients [22].
Most of the studies have focused on the prevalence of IBS among different populations [10,23,24], rather than the awareness and knowledge about IBS among the general public. The present study was performed as the first study to evaluate the public’s knowledge about IBS and its risk factors in the Aseer Region, Saudi Arabia. The questionnaire used in the study was validated and revised to focus on knowledge about the cause, nature, risk factors, and management of this syndrome. Thus, this study did not replicate the questionnaires or data of the previous published.
The etiology of IBS remains unknown, lacking confirmed or known factors. It has been advocated that the pathophysiology of IBS is not yet properly understood. For explaining the pathogenesis of diseases, various linked risk factors have been proposed. Recently, a “biopsychosocial” model has been proposed in an endeavor to harmonize and integrate various factors (such as environmental, genetic, and psychological) that work together synergistically to generate different signs and symptoms [24].
According to the findings of this study, most of the adults in the Aseer Region of Saudi Arabia are familiar with irritable bowel syndrome (IBS), and the vast majority of these individuals have accurate knowledge regarding the disorder’s etiology, symptoms, risk factors, prognosis, and management, particularly among university-educated subjects. On the other hand, the results of the bivariate and multivariate analyses suggested that knowledge of IBS was considerably lower among participants who were obese, younger, married, and had a lower level of education.
However, the study by Hakami et al., which aimed to assess the knowledge, attitude, and practices of medical students in Saudi Arabia toward IBS, reported that most participants had misconceptions about its etiology and nature [25]. Similarly, several other national [26,27] and international studies [28,29,30] reported low awareness of IBS among the study populations, as most of the subjects had improper knowledge about the etiology and risk factors of IBS and its symptoms.
The present study also revealed that the general public has adequate knowledge about the risks and aggravating factors of IBS. Most subjects will seek medicinal treatment and professional counseling for the management of IBS. Similar findings were reported in several studies [27,28,29], whose participants advocated the need for awareness about IBS and various factors related to the disease.

Strengths and Limitations

The present study was the first to explore the knowledge and related risk factors for IBS among the general public in Aseer Region, Saudi Arabia. However, this study has a few limitations, such as the cross-sectional nature of the study design, and the non-probability sampling used to include participants, which may reflect a selection bias. Moreover, the majority of participants were of young and middle age, and most respondents were highly educated, which may reflect some degree of response bias. In addition, the study did not inquire about the relatives of the participants who may suffer from IBS. Further studies should be conducted on a larger sample size, involving different parameters and variables to study the knowledge, attitude, and awareness among study subjects in relation to IBS.

5. Conclusions

Most of the adult Saudi general public has good knowledge about the etiology, symptoms, risk factors, prognosis, and management of IBS. However, further observational studies need to be conducted with an elaborated sample size that includes an equal distribution of subjects of different age groups, genders, and educational levels from different areas of Saudi Arabia to assess the knowledge and awareness regarding IBS and the actual prevalence of the disease among the general population in Saudi Arabia. It is also recommended to conduct various healthcare programs to enhance knowledge and raise the public’s awareness about IBS.

Author Contributions

All the authors contributed to the study conception and design. Material preparation, data collection was performed by F.N.M.A., K.A.M.A., A.M.A., B.A.A. and M.M.A. Analysis’ was performed by M.J.B., M.A.B. and R.M.E. The first draft of the manuscript was written by M.A.B. and M.J.B. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The research protocol was approved by the Research Ethics committee at King Khalid University(approval number:(ECM#2020-2402) and all necessary precautions were taken.

Informed Consent Statement

Informed written consent was obtained from all subjects prior to their enrollment in the study. Patients were clearly informed about the questionnaire and the responses to all questions were recorded and analyzed.

Data Availability Statement

The data will be available with the corresponding author to be releases on reasonable request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Loosen, S.H.; Kostev, K.; Jördens, M.S.; Luedde, T.; Roderburg, C. Overlap between irritable bowel syndrome and common gastrointestinal diagnoses: A retrospective cohort study of 29,553 outpatients in Germany. BMC Gastroenterol. 2022, 22, 48. [Google Scholar] [CrossRef]
  2. Jeffery, I.B.; O’toole, P.W.; Öhman, L.; Claesson, M.J.; Deane, J.; Quigley, E.M.; Simrén, M. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 2012, 61, 997–1006. [Google Scholar] [CrossRef]
  3. Masuy, I.; Pannemans, J.; Tack, J. Irritable bowel syndrome: Diagnosis and management. Minerva. Gastroenterol. Dietol. 2019, 66, 136–150. [Google Scholar] [CrossRef]
  4. Bin Abdulrahman, K.A.; Alenazi, N.S.; Albishri, S.B.; Alshehri, F.F. Association of Migraine and Irritable Bowel Syndrome in Saudi Arabia: A Nationwide Survey. BioMed. Res. Int. 2022, 2022, 8690562. [Google Scholar] [CrossRef]
  5. Lacy, B.E.; Patel, N.K. Rome criteria and a diagnostic approach to irritable bowel syndrome. J. Clin. Med. 2017, 6, 99. [Google Scholar] [CrossRef] [PubMed]
  6. Spiegel, B.M.; Farid, M.; Esrailian, E.; Talley, J.; Chang, L. Is irritable bowel syndrome a diagnosis of exclusion?: A survey of primary care providers, gastroenterologists, and IBS experts. Am. J. Gastroenterol. 2010, 105, 848. [Google Scholar] [CrossRef] [Green Version]
  7. Hsiao, C.W.; Huang, W.Y.; Ke, T.W.; Muo, C.H.; Chen, W.T.L.; Sung, F.C.; Kao, C.H. Association between irritable bowel syndrome and colorectal cancer: A nationwide population-based study. Eur. J. Int. Med. 2014, 25, 82–86. [Google Scholar] [CrossRef] [PubMed]
  8. Rodríguez, L.G.; Ruigómez, A.; Wallander, M.A.; Johansson, S.; Olbe, L. Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome. Scand. J. Gastroenterol. 2000, 35, 306–311. [Google Scholar]
  9. Lai, Y.T.; Chen, C.Y.; Bair, M.J. Epidemiology, Clinical Features, and Prescribing Patterns of Irritable Bowel Syndrome in Taiwan. Front. Pharmacol. 2021, 12, 788795. [Google Scholar] [CrossRef]
  10. Al Butaysh, O.F.; Al Quraini, A.A.; Almukhaitah, A.A.; Alahmdi, Y.M.; Alharbi, F.S. Epidemiology of irritable bowel syndrome and its associated factors in Saudi undergraduate students. Saudi J. Gastroenterol. 2020, 26, 89–93. [Google Scholar]
  11. Chey, W.D.; Kurlander, J.; Eswaran, S. Irritable Bowel Syndrome: A Clinical Review. JAMA 2015, 313, 949–958. [Google Scholar]
  12. Mayer, E.A.; Labus, J.S.; Tillisch, K.; Cole, S.W.; Baldi, P. Towards a systems view of IBS. Nat. Rev. Gastroenterol. Hepatol. 2015, 12, 592–605. [Google Scholar] [CrossRef] [Green Version]
  13. Lacy, B.E.; Cangemi, D.J.; Spiegel, B.R. Virtual Reality: A New Treatment Paradigm for Disorders of Gut-Brain Interaction? Gastroenterol. Hepatol. 2023, 19, 86. [Google Scholar]
  14. Jagielski, C.H.; Riehl, M.E. Behavioral Strategies for Irritable Bowel Syndrome: Brain-Gut or Gut-Brain? Gastroenterol. Clin. 2021, 50, 581–593. [Google Scholar]
  15. Lacy, B.E.; Pimentel, M.; Brenner, D.M.; Chey, W.D.; Keefer, L.A.; Long, M.D.; Moshiree, B. ACG clinical guideline: Management of irritable bowel syndrome. Am. Coll. Gastroenterol. 2021, 116, 17–44. [Google Scholar] [CrossRef] [PubMed]
  16. Alhaznn, A. Irritable bowel syndrome in secondary school male students in AlJouf Province, north of Saudi Arabia. J. Pak. Med. Assoc. 2011, 61, 1111. [Google Scholar]
  17. Cho, H.S.; Park, J.M.; Lim, C.H.; Cho, Y.K.; Lee, I.S.; Kim, S.W.; Choi, M.G.; Chung, I.S.; Chung, Y.K. Anxiety, depression and quality of life in patients with irritable bowel syndrome. Gut Liver 2011, 5, 29–36. [Google Scholar] [CrossRef] [Green Version]
  18. Qin, H.Y.; Cheng, C.W.; Tang, X.D.; Bian, Z.X. Impact of psychological stress on irritable bowel syndrome. World J. Gastroenterol. 2014, 20, 14126–14131. [Google Scholar] [CrossRef]
  19. Peter, J.; Fournier, C.; Durdevic, M.; Knoblich, L.; Keip, B.; Dejaco, C.; Trauner, M.; Moser, G. A microbial signature of psychological distress in irritable bowel syndrome. Psychosom. Med. 2018, 80, 698. [Google Scholar] [CrossRef]
  20. Ibrahim, N.K.; Battarjee, W.F.; Almehmadi, S.A. Prevalence and predictors of irritable bowel syndrome among medical students and interns in King Abdulaziz University, Jeddah. Libyan J. Med. 2013, 8, 21287. [Google Scholar] [CrossRef]
  21. AlKhalifah, M.I.; Al-Aql, A.M.; Al-Mutairi, M.S.; Alnuqaydan, S.A.; Al-Wehaibi, A.S.; AlJurayyed, A.M.; Aldhuwyan, A.S.; Al-Harbi, K.G.; Alomar, I.N.; Alayyaf, S.S.; et al. Prevalence of irritable bowel syndrome among Qassim school teachers, and its impact on their performance and life duties. Saudi Med. J. 2016, 37, 817. [Google Scholar] [CrossRef]
  22. Alqahtani, N.H.; Mahfouz, M.E. The prevalence and risk factors of irritable bowel syndrome in Saudi Arabia in 2019. Int. J. Prev. Med. 2022, 13, 13. [Google Scholar] [CrossRef] [PubMed]
  23. Ahmed, S.A.S.; Alotaibi, Y.M.; Alayed, S.I.; Al Alshaykh, O.M.; Alothman, O.M.; Alhumaidi, A.A. Prevalence of irritable bowel syndrome among medical students in Imam Mohammad Ibn Saud Islamic University. Int. J. Med. Dev. Ctries. 2020, 4, 896–901. [Google Scholar] [CrossRef]
  24. Aziz, I.; Simrén, M. The overlap between irritable bowel syndrome and organic gastrointestinal diseases. Lancet Gastroenterol. Hepatol. 2021, 6, 139–148. [Google Scholar] [CrossRef]
  25. Hakami, R.M.; Elmakki, E.; Hasanain, T.; Alnami, A.; Khawaji, A.; Ali, L.; Tobaigy, M.; Allayl, A.; Faqihi, I.; Bajoned, M.; et al. Irritable Bowel Syndrome: Assessment of prevalence and risk factors in Saudi University students using Rome IV Criteria. Gastroenterol. Insights 2019, 10, 8239. [Google Scholar] [CrossRef] [Green Version]
  26. Arishi, A.M.; Elmakki, E.E.; Hakami, O.M.; Alganmy, O.M.; Maashi, S.M.; Al-Khairat, H.K.; Sahal, Y.A.; Sharif, A.A.; Alfaifi, M.H. Irritable bowel syndrome: Prevalence and risk factors in Jazan Region, Saudi Arabia. Cureus 2021, 13, e15979. [Google Scholar] [CrossRef]
  27. Khan, A.; Alsayegh, H.; Ali, M.; Qurini, A.; AlKhars, H.; AlKhars, A. Assessment of Knowledge and Related Risk Factors of Irritable Bowel Syndrome in Alahsa, Saudi Arabia. Int. J. Med. Dev. Ctries. 2019, 3, 30–35. [Google Scholar] [CrossRef]
  28. Lavekar, A.; Chandran, S.; Ram, D.; Sadar, A.; Manjari, K.S. Awareness about Irritable Bowel Syndrome among Interns of Medical College. Age 2018, 24, 13–19. [Google Scholar] [CrossRef]
  29. Spiegel, B.M.; Gralnek, I.M.; Bolus, R.; Chang, L.; Dulai, G.S.; Mayer, E.A.; Naliboff, B. Clinical determinants of health-related quality of life in patients with irritable bowel syndrome. Arch. Int. Med. 2004, 164, 1773–1780. [Google Scholar] [CrossRef] [Green Version]
  30. Szałwińska, P.; Włodarczyk, J.; Spinelli, A.; Fichna, J.; Włodarczyk, M. IBS-symptoms in IBD patients—Manifestation of concomitant or different entities. J. Clin. Med. 2020, 10, 31. [Google Scholar] [CrossRef]
Figure 1. General public’s awareness regarding irritable bowel syndrome.
Figure 1. General public’s awareness regarding irritable bowel syndrome.
Healthcare 11 01084 g001
Table 1. Demographic data (n = 779).
Table 1. Demographic data (n = 779).
ParametersNo. of SubjectsPercentage
ResidenceWithin Aseer Region61779.2
Outside Aseer Region16220.8
GenderMale33743.3
Female44256.7
Age (years)<20678.6
21–3028636.7
31–4018023.1
≥4024631.6
Marital statusMarried45258.0
Single32742.0
Education levelIlliterate20.3
Primary (finished 6 years of school education)131.7
Intermediate (finished 9 years of school education273.5
Secondary (finished 12 years of school education)15820.3
University53568.7
Postgraduate445.6
JobStudent 24932.0
Teacher 21727.9
Administrative131.7
Military212.7
Not employed/housewife16821.6
Govt employee121.5
Retired354.5
Private sector employee425.4
Other222.8
Body mass index (kg/m2)Underweight425.4
Normal weight24130.9
Overweight30839.5
Obese18824.1
Table 2. Participants’ responses to knowledge items related to IBS.
Table 2. Participants’ responses to knowledge items related to IBS.
ParametersOptionsNo. of SubjectsPercentage
  • Have you ever heard about irritable bowel syndrome?
Yes
(n = 555, 71.2%)
The Internet and social media20036.0
Competent person/specialized facility7613.7
Relatives or friends27449.4
Others61.1
No22428.8
2.
Irritable bowel syndrome includes the following:
Diarrhea/constipation/abdominal cramps24531.5
Colon infection47460.8
Change in appetite141.8
Ulcers in the bowel465.9
Inflammation of the bowel00
3.
Irritable bowel syndrome is more common than diabetes or hypertension.
True22428.8
False13016.7
I do not know42554.6
4.
Do you think Irritable bowel syndrome affects the quality of life?
Yes61979.5
No395.0
I do not know12115.5
5.
Irritable bowel syndrome can lead to rapid mood changes.
Yes71992.3
No81.0
I do not know526.7
6.
What do you think is the most irritating symptom that makes the patient uncomfortable?
(more than one option is allowed)
Abdominal pain 48662.4
Excess gases 43956.4
Diarrhea 638.1
Constipation28536.6
7.
Irritable bowel syndrome is a result of the following: (you can choose more than one)
Genetic factors 29738.1
Infections 13717.6
Dietary factors/food allergy 38148.9
Anxiety/depression/stress 24331.2
Motility problem121.5
8.
Irritable bowel syndrome can lead to the following: (you can choose more than one)
Cancer 35345.3
Ulcer 41453.1
Malnutrition 16320.9
Absorption disorders23730.4
Hemorrhoid13717.6
9.
Irritable bowel syndrome attacks/episodes are triggered by the following: (you can choose more than one)
A combination of multiple factors 34043.6
Eating spicy foods 405.1
Frequent and excessive intake of meals12716.3
Eating a lot of meals containing saturated fat435.5
By coffee10413.4
By stress at work or in relationships 24030.8
10.
Dietary changes could improve irritable bowel syndrome symptoms.
Yes62380.0
No182.3
I do not know13817.7
11.
Prescription medications could improve irritable bowel syndrome symptoms.
Yes55871.6
No334.2
I do not know18824.1
12.
Surgery could improve the irritable bowel syndrome status.
Yes8310.7
No14618.7
I do not know55070.6
13.
Counselling (a gastroenterologist, psychiatrist, or psychologist) could improve the irritable bowel syndrome status.
Yes63076.64
No263.3
I do not know60077.0
14.
Advanced age is a major cause of irritable bowel syndrome.
Yes17021.8
No24932.0
May be36046.2
15.
If one of your relatives has symptoms of irritable bowel syndrome and he/she seeks your advice, what would you do?
(more than one option is allowed)
Offer them some herbal medications 12816.4
Tell them to change their diet 29337.6
Tell them to visit a gastroenterologist 30238.8
You will not tell them anything15119.4
16.
What would you like to know about irritable bowel syndrome?
What irritable bowel syndrome is 52767.7
What causes irritable bowel syndrome 364.6
What foods should I avoid 9111.7
Medications to prevent attack10.1
Nothing12415.9
Table 3. Participants’ awareness regarding IBS according to their personal characteristics.
Table 3. Participants’ awareness regarding IBS according to their personal characteristics.
Unaware (n = 230)Aware (n = 549)p
Personal CharacteristicsNo.%No.%Value
ResidenceOutside Aseer Region5332.710967.3
Within Aseer Region 17728.744071.30.318
GenderMale8124.225675.8
Female14933.629366.40.004
Age (in years)<201928.04872.0
21–304716.423983.6
31–404927.313172.7<0.001
> 4011546.713153.3
Marital statusMarried16636.728663.3
Single6419.626380.4<0.001
Educational levelIlliterate150.0150.0
Primary528.6871.4
Intermediate1242.91557.1
Secondary5937.69962.40.037
University14426.939173.1
Postgraduate921.33578.7
Body mass indexUnderweight13312969
Normal weight5020.719179.3
Overweight10233.120666.90.005
Obese653412366
Table 4. Binary logistic regression for independent variables affecting awareness of IBS.
Table 4. Binary logistic regression for independent variables affecting awareness of IBS.
Standard Expp95% CI for Exp(B)
VariablesBErrorWald(B)ValueLowerUpper
Gender1.860.3234.526.40<0.0013.4511.89
Age groups1.680.1976.925.37<0.0013.697.83
Marital status1.310.3712.393.69<0.0011.787.63
Educational level1.500.1962.914.49<0.0013.106.50
Body mass index1.260.1850.373.54<0.0012.505.02
Constant−13.721.28115.670.00<0.001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Bawahab, M.A.; Bhat, M.J.; Asiri, F.N.M.; Alshahrani, K.A.M.; Alshehri, A.M.; Almutairi, B.A.; Alhumaidi, M.M.; Eskandar, R.M. Assessment of Public’s Awareness Regarding Irritable Bowel Syndrome in Aseer Region, Saudi Arabia. Healthcare 2023, 11, 1084. https://doi.org/10.3390/healthcare11081084

AMA Style

Bawahab MA, Bhat MJ, Asiri FNM, Alshahrani KAM, Alshehri AM, Almutairi BA, Alhumaidi MM, Eskandar RM. Assessment of Public’s Awareness Regarding Irritable Bowel Syndrome in Aseer Region, Saudi Arabia. Healthcare. 2023; 11(8):1084. https://doi.org/10.3390/healthcare11081084

Chicago/Turabian Style

Bawahab, Mohammed A., Muneer Jan Bhat, Fahad Nasser Mohammed Asiri, Khalid Ali Mohammed Alshahrani, Abdulaziz Mohammed Alshehri, Bassam Ahmed Almutairi, Muath Mohammed Alhumaidi, and Rayan M. Eskandar. 2023. "Assessment of Public’s Awareness Regarding Irritable Bowel Syndrome in Aseer Region, Saudi Arabia" Healthcare 11, no. 8: 1084. https://doi.org/10.3390/healthcare11081084

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop